-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
R&D base
05
2024-11
"The Guide for Digital Transformation in Pharmaceutical Companies" covers multiple aspects, including transformation planning, resource support, operational implementation, evaluation and inspection, as well as continuous improvement. It aims to help enterprises establish a scientific digital transformation framework, enabling the reengineering and optimization of business processes, and ultimately enhancing their core competitiveness and market responsiveness.
2024-11-05
02
2024-11
This significant achievement marks that the product is now fully ready for market launch, showcasing not only Keyuan Pharmaceutical's outstanding success in the field of chemical API R&D, but also highlighting its strong capabilities in production transformation and quality management.
2024-11-02
01
2024-11
Quality is the core competitiveness that determines a company's survival. Keyuan Pharmaceutical consistently strives to build a market-oriented quality management system aligned with international standards, and has organized a series of quality training sessions and competitions to enhance everyone's awareness of quality across the organization.
2024-11-01
22
2024-10
This training session specially invited Liu Xingcun, Vice President of Linuo Group and Dean of the Digital Intelligence Research Institute, as the speaker. Attendees included heads of relevant departments and core employees from Keyuan Pharmaceutical. The training covered various aspects, including CMMM’s core principles, implementation steps, and sharing of successful case studies. Dean Liu Xingcun provided attendees with a comprehensive and insightful understanding of CMMM through clear explanations and engaging case analyses.
2024-10-22
11
2024-10
Keyuan Pharmaceutical shines at CPHI Milan 2024, adding new momentum to its global journey!
From October 8 to 10, CPHI Milan 2024—the global pharmaceutical industry’s premier event—officially kicked off with great fanfare in Milan, Italy. As one of the most influential trade shows in the global pharmaceutical sector, this year’s exhibition brought together pharmaceutical raw material suppliers, manufacturers, R&D institutions, and industry professionals from around the world, fostering discussions on emerging trends, pressing challenges, and promising opportunities shaping the future of the pharmaceutical industry.
2024-10-11
22
2024-09
As a pioneer in digital and intelligent pharmaceuticals, Keyuan Pharmaceutical has consistently embraced lean manufacturing as one of the core principles driving its business growth. Since March, the company has established a Lean Promotion Committee, leveraging initiatives such as fostering lean awareness across the organization and implementing advanced tools like digital and intelligent lean value-stream analysis. As a result, the company has achieved remarkable improvements at its benchmark factory.
2024-09-22
08
2024-09
At 30, we stand firm with vibrant energy, steadily moving forward with practical action toward the future! On September 28, Linuo Group celebrated a significant milestone in its remarkable journey—its 30th anniversary.
2024-09-08
02
2024-09
Recently, the China United Nations Procurement Promotion Association released the group standard T/UNP 178—2024, "Guidelines for Digital Transformation in Pharmaceutical Companies," marking a significant step forward for China's pharmaceutical enterprises in their digital transformation journey.
2024-09-02
27
2024-08
To accelerate the entry of several company products into international markets and further enhance the competitive edge of "industrial globalization," Keyuan Pharmaceutical (stock code: 301281.SZ) recently held a special international registration conference. Senior management, the R&D team, and international registration experts gathered together to jointly discuss and map out implementation strategies for the international registration of multiple company products, providing robust product support to continuously boost Keyuan Pharmaceutical's export revenue.
2024-08-27
23
2024-08
Recently, Keyuan Pharmaceutical (stock code: 301281.SZ) successfully held a unique Internship Report Meeting for Management Trainees, accompanied by a mentorship agreement signing ceremony. This event not only highlighted Keyuan Pharmaceutical's strong commitment to talent development but also underscored the company's deep appreciation for the time-honored practices of mentorship and the enduring legacy of craftsmanship.
2024-08-23
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline